PROCTER & GAMBLE HEALTH | HIKAL. | PROCTER & GAMBLE HEALTH/ HIKAL. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 53.8 | 64.4% | View Chart |
P/BV | x | 10.6 | 3.4 | 310.7% | View Chart |
Dividend Yield | % | 2.0 | 0.4 | 523.3% |
PROCTER & GAMBLE HEALTH HIKAL. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
HIKAL. Mar-23 |
PROCTER & GAMBLE HEALTH/ HIKAL. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 456 | 1,176.2% | |
Low | Rs | 3,883 | 216 | 1,800.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 164.1 | 451.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | 6.4 | 2,174.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 15.2 | 1,020.9% | |
Dividends per share (Unadj.) | Rs | 95.00 | 1.20 | 7,916.7% | |
Avg Dividend yield | % | 2.1 | 0.4 | 575.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 91.9 | 486.9% | |
Shares outstanding (eoy) | m | 16.60 | 123.30 | 13.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.0 | 304.9% | |
Avg P/E ratio | x | 33.5 | 52.8 | 63.3% | |
P/CF ratio (eoy) | x | 29.8 | 22.1 | 134.8% | |
Price / Book Value ratio | x | 10.3 | 3.7 | 282.7% | |
Dividend payout | % | 68.7 | 18.9 | 364.0% | |
Avg Mkt Cap | Rs m | 76,761 | 41,420 | 185.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 2,224 | 92.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 20,230 | 60.8% | |
Other income | Rs m | 184 | 54 | 339.9% | |
Total revenues | Rs m | 12,480 | 20,284 | 61.5% | |
Gross profit | Rs m | 3,247 | 2,571 | 126.3% | |
Depreciation | Rs m | 281 | 1,090 | 25.8% | |
Interest | Rs m | 8 | 481 | 1.6% | |
Profit before tax | Rs m | 3,142 | 1,054 | 298.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 270 | 314.0% | |
Profit after tax | Rs m | 2,295 | 784 | 292.8% | |
Gross profit margin | % | 26.4 | 12.7 | 207.8% | |
Effective tax rate | % | 27.0 | 25.6 | 105.3% | |
Net profit margin | % | 18.7 | 3.9 | 481.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 9,683 | 121.0% | |
Current liabilities | Rs m | 6,791 | 6,908 | 98.3% | |
Net working cap to sales | % | 40.0 | 13.7 | 291.9% | |
Current ratio | x | 1.7 | 1.4 | 123.1% | |
Inventory Days | Days | 263 | 26 | 1,026.0% | |
Debtors Days | Days | 343 | 80 | 430.9% | |
Net fixed assets | Rs m | 10,617 | 15,024 | 70.7% | |
Share capital | Rs m | 166 | 247 | 67.3% | |
"Free" reserves | Rs m | 7,265 | 11,088 | 65.5% | |
Net worth | Rs m | 7,431 | 11,335 | 65.6% | |
Long term debt | Rs m | 0 | 4,899 | 0.0% | |
Total assets | Rs m | 22,330 | 24,707 | 90.4% | |
Interest coverage | x | 409.1 | 3.2 | 12,821.0% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 67.3% | |
Return on assets | % | 10.3 | 5.1 | 201.4% | |
Return on equity | % | 30.9 | 6.9 | 446.6% | |
Return on capital | % | 42.4 | 9.5 | 448.4% | |
Exports to sales | % | 0 | 67.6 | 0.0% | |
Imports to sales | % | 13.1 | 25.6 | 51.0% | |
Exports (fob) | Rs m | NA | 13,684 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 5,184 | 31.0% | |
Fx inflow | Rs m | 1,465 | 13,684 | 10.7% | |
Fx outflow | Rs m | 1,605 | 5,184 | 31.0% | |
Net fx | Rs m | -140 | 8,500 | -1.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 3,153 | 74.8% | |
From Investments | Rs m | -215 | -2,923 | 7.4% | |
From Financial Activity | Rs m | -985 | -77 | 1,282.2% | |
Net Cashflow | Rs m | 1,160 | 153 | 758.9% |
Indian Promoters | % | 0.0 | 68.9 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 10.1 | 198.1% | |
FIIs | % | 6.2 | 6.6 | 95.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 31.2 | 154.7% | |
Shareholders | 56,778 | 71,840 | 79.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | HIKAL CHEMIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.89% | 0.45% |
1-Month | -1.15% | 15.84% | 2.55% |
1-Year | 0.73% | 7.45% | 56.14% |
3-Year CAGR | -8.76% | 12.68% | 15.22% |
5-Year CAGR | 4.97% | 11.59% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the HIKAL CHEMIC share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of HIKAL CHEMIC the stake stands at 68.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of HIKAL CHEMIC.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
HIKAL CHEMIC paid Rs 1.2, and its dividend payout ratio stood at 18.9%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of HIKAL CHEMIC.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.